Prenatal genetic testing provides early insight into your baby’s chromosomal health through a simple maternal blood draw. Non-Invasive Prenatal Testing (NIPT) analyzes small fragments of fetal DNA circulating in the mother’s bloodstream to screen for common chromosomal conditions.

NIPT can typically be performed from 10 weeks of pregnancy and screens for conditions such as trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and certain sex chromosome abnormalities. Some advanced panels may also assess additional chromosomal variations.

This testing is non-invasive and poses no risk to the fetus. It offers highly accurate screening information to support informed prenatal decision-making.

All testing is processed through accredited laboratories to ensure clinical accuracy and reliable results.